Isodiol International Inc (ISOLF)
0.00
USD |
OTCM |
Apr 25, 16:00
Isodiol International Shareholders Equity (Quarterly): -0.3172M for Dec. 31, 2019
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
December 31, 2019 | -0.3172M |
September 30, 2019 | 0.4731M |
June 30, 2019 | 2.712M |
March 31, 2019 | 5.192M |
December 31, 2018 | 66.99M |
September 30, 2018 | 82.03M |
June 30, 2018 | 85.59M |
March 31, 2018 | 36.99M |
December 31, 2017 | 42.08M |
June 30, 2017 | 8.827M |
March 31, 2017 | 1.428M |
Date | Value |
---|---|
December 31, 2016 | 0.2538M |
September 30, 2016 | -0.3909M |
June 30, 2016 | -0.536M |
March 31, 2016 | -0.5722M |
December 31, 2015 | -0.5065M |
September 30, 2015 | -0.2002M |
June 30, 2015 | 0.4561M |
March 31, 2015 | -0.2663M |
December 31, 2014 | 0.1249M |
September 30, 2014 | 0.2284M |
June 30, 2014 | 0.3058M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-0.3172M
Minimum
Dec 2019
2.712M
Maximum
Jun 2019
0.9559M
Average
0.4731M
Median
Sep 2019
Shareholders Equity (Quarterly) Benchmarks
Acasti Pharma Inc | 64.68M |
Aurinia Pharmaceuticals Inc | 377.95M |
Edesa Biotech Inc | 5.845M |
Lexaria Bioscience Corp | 6.521M |
Liminal Biosciences Inc (DELISTED) | 16.20M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 8.443M |
Total Liabilities (Quarterly) | 8.760M |